Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis. [PDF]
Li N +11 more
europepmc +1 more source
Development and validation of a novel interpretable machine learning model integrating immune-inflammatory indicators for intravenous immunoglobulin resistance in Kawasaki disease. [PDF]
Shi T +6 more
europepmc +1 more source
Molecular and immunological biomarkers to predict IVIg response.
C. Galeotti, S. Kaveri, J. Bayry
semanticscholar +1 more source
Almost Three Decades of Post-Marketing Experience With A Human Intravenous Immunoglobulin 5%: Analysis of A Propriety Pharmacovigilance Database. [PDF]
Susini D +4 more
europepmc +1 more source
Clindamycin and intravenous immunoglobulins in pediatric invasive group A streptococcal disease: what is the evidence? [PDF]
van Kempen EB +4 more
europepmc +1 more source
Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab. [PDF]
Smits F +9 more
europepmc +1 more source
Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study. [PDF]
Mastrolia MV +33 more
europepmc +1 more source
E. Nobile-Orazio +16 more
semanticscholar +1 more source

